Objective: To determine the frequency and yield of neuroimaging in patients with known seizure disorders presenting to the emergency department (ED) with recurrent (nonindex) seizures. Methods: We reviewed 822 consecutive ED visits for nonindex seizures at the Oregon Health & Science University and the VA Portland Health Care System. For each visit, we abstracted details of the clinical presentation, whether neuroimaging was obtained, the results of neuroimaging, and the results of previous neuroimaging studies, when available. We determined whether ED neuroimaging led to an acute change in patient management (yield). Clinical factors associated with obtaining ED neuroimaging, and with the yield of neuroimaging, were evaluated by multivariate logistic regression. Results: A majority (78%) of ED seizure visits were for nonindex seizures. Neuroimaging was obtained in 381 of 822 nonindex seizure visits (46%). Of these, 11 imaging studies (3%) led to an acute change in patient management, 8 (2%) after excluding false-positive scans. Acute head trauma, prolonged alteration of consciousness, and a focal neurologic examination at presentation were associated with an increased yield of ED neuroimaging. Absent any of these 3 clinical factors the true positive yield of neuroimaging was zero. Significance: ED neuroimaging was performed in nearly half of all patients presenting with nonindex seizures. A more conservative use of ED neuroimaging for nonindex seizures, based on clinical factors at presentation, could decrease imaging frequency with minimal loss of yield.
recommended consideration of emergency CT in these patients. However, the value of neuroimaging in patients with known seizure disorders ("nonindex" seizures) was uncertain. Based on limited evidence, "… the likelihood of an imaging study changing management for emergency patients with chronic seizures is not available." 8 No recommendations were made. We studied ED neuroimaging for nonindex seizures and addressed 3 questions: (1) How often is ED neuroimaging obtained? (2) What is the yield; findings that led to an acute change in management? (3) What clinical or historical factors influenced whether ED neuroimaging was obtained, and the yield of neuroimaging? The study was conducted independently at 2 medical centers to better represent variations in hospital practice.
| METHODS

| Study design and setting
A retrospective chart review of consecutive patients presenting to the EDs of 2 hospitals with nonindex seizures (defined as recurrent seizures in patients with a previously established seizure disorder).
| Selection of participants
We searched the ED databases of the Oregon Health & Science University (OHSU, 2010 (OHSU, -2012 ) and the VA Portland Health Care System (VAPOR; 2008-2012) for all patients ≥18 years old with a primary International Classifications of Diseases, Ninth Revision (ICD-9) seizure diagnosis code for the ED visit (345.xx , 780.33, 780.39). All charts were reviewed including 795 ED visits at OHSU and 753 ED visits at VAPOR. We excluded the following patients: (1) those with an "index" seizure (defined as the first seizure brought to medical attention, even if not the first seizure); (2) with a nonindex seizure but no seizures in ≥5 years (these patients are often evaluated as if the presenting seizure is an index seizure); (3) who had undergone neuroimaging at another hospital prior to transfer to the OHSU or VAPOR ED; and (4) who did not have an acute seizure as the primary reason for the ED visit (patients with syncope, psychogenic seizure, unclear diagnosis, and so on). Many of these charts were incorrectly coded.
| Chart review
Investigators were trained on chart review procedures and definitions through group meetings and the use of a chart review manual prepared specifically for this study. To further improve uniformity across reviewers, all charts underwent a second review by the principal investigator (MS).
Studies were performed independently at the 2 hospitals using identical protocols.
| Seizure characteristics/physical examination
For each ED visit, we abstracted clinical characteristics of the seizure and the ED physical examination, including (1) seizure type; (2) whether the seizure was convulsive; (3) whether the patient was receiving prescribed antiepileptic drugs (AEDs; regardless of whether the drugs were being taken); (4) presentation with status epilepticus or acute repetitive seizures (ARS); (5) whether the seizure was associated with an acute head injury (based on ED notes), and if so the severity of the injury (Annegers criteria) 9 ; (6) whether the seizure was thought to be associated with alcohol abuse/withdrawal, or recreational drug use; (7) evidence of prolonged alteration of consciousness (AOC, ≥60 minutes) after the seizure; (8) evidence of a focal onset or progression of the seizure; and (9) a focal abnormality on the ED neurologic examination. Selection of these clinical characteristics was based on previous studies and clinical experience. 8, [10] [11] [12] We also recorded a documented history of brain tumor, stroke, or traumatic brain injury (TBI).
| ED neuroimaging
We determined whether neuroimaging (CT, magnetic resonance imaging [MRI], or both) was obtained as part of each ED visit by review of ED notes and hospital imaging reports in the electronic medical record (EMR). When imaging was obtained, we recorded whether the study was
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| Previous neuroimaging
We recorded the results of previous neuroimaging (neuroimaging that had been obtained prior to the date of the ED visit), when available. Results of previous neuroimaging were found through the EMR including multisite records linkage, available at both hospitals. We only included radiology reports as opposed to second-hand accounts. We did not request/review records that were unavailable through the EMR. The date and type of previous neuroimaging were recorded. As with current neuroimaging, previous neuroimaging scans were classified as normal vs abnormal. The likelihood of an epileptogenic lesion and details of abnormalities were recorded.
| Analysis
Univariate comparisons of patient characteristics (OHSU vs VAPOR) utilized Fisher's exact test (categorical data) or the Wilcoxon test (continuous data). We calculated 95% confidence intervals (CIs) for the yield of neuroimaging using binomial proportions. The influence of several clinical and historical factors on obtaining ED neuroimaging (vs not obtaining neuroimaging), and on the yield of ED neuroimaging (an acute change in management vs no acute change in management), was tested using Fisher's exact tests, stratified by hospital. Odds ratios (ORs) and CIs were calculated separately for the OHSU and VAPOR samples and compared using the Breslow-Day test (for homogeneity of ORs). Because the ORs were not significantly different for any of these factors, the results from the 2 hospitals were combined and Cochran-Mantel-Haenszel statistics were calculated. Multivariate logistic regression was used to determine significant multivariate effects of clinical and historical factors on obtaining ED neuroimaging and on the yield of neuroimaging. ORs and Wald CIs were calculated. Significance levels were 2-sided. All analyses were performed on SAS software v9.4 (SAS Inc., Cary, North Carolina).
| Standard protocol approvals and registrations
The study was approved by the institutional review boards and ethical standards committees of OHSU and VAPOR.
3 | RESULTS
| Characteristics of study subjects
After exclusions, there were 477 ED visits at OHSU (331 unique patients) and 345 ED visits at VAPOR (215 unique patients)-a total of 822 visits. All patients had nonindex seizures as the primary reason for ED presentation. The most common reasons for exclusion were an index seizure or a different (nonseizure) primary diagnosis. Among all patients presenting to the EDs for ES (index+nonindex), 78% had nonindex seizures. Characteristics of the study groups are provided in Table 1 . VAPOR patients were on average older than OHSU patients and were more often male, consistent with the populations from which the patients were drawn. Most seizures were convulsive, and most patients were supposed to be taking AEDs at the time of presentation. Acute head traumas were charted in 15% and 10% of OHSU and VAPOR ED visits, respectively. All head traumas were classified as mild based on ED notes. In most cases, (70%), the head injury was associated with a convulsive seizure. Hospitalizations were more common at VAPOR vs OHSU. The reasons for hospitalization differed. At OHSU, 85% of hospital admissions were related primarily to seizures, whereas at VAPOR, 69% were seizure-related, and 31% were related primarily to other medical issues.
| ED neuroimaging; frequency and results
Neuroimaging was obtained during the ED visit in 185 OHSU patients (39% of all visits) and 196 VAPOR patients (57% of all visits; P < 0.001 vs OHSU) ( Figure 1 ). The combined neuroimaging rate was 46%. After correction for patient age, the difference in imaging frequency between hospitals was no longer significant. Most patients underwent CT scan only (93% of OHSU scans, 95% of VAPOR scans).
ED neuroimaging was interpreted as abnormal in 65% and 54% of OHSU and VAPOR patients, respectively. Within the group of abnormal scans, 81% and 67%, respectively, revealed a potentially epileptogenic lesion. For the entire sample, 44% of all ED scans revealed a potentially epileptogenic lesion. The most common abnormality was cortical encephalomalacia (posttraumatic, postsurgical, or other) accounting for 43% and 36% of abnormal scans at OHSU and VAPOR, respectively. Details of all neuroimaging abnormalities are provided in Table S1 .
Most patients who had ED neuroimaging also had results from previous neuroimaging available in the hospital electronic medical record (EMR; 86% of OHSU patients, 93% of VAPOR patients). The median interval between the most recent neuroimaging and the current ED neuroimaging was 117 days at OHSU and 282 days at VAPOR. Overall, 67% of patients with ED neuroimaging had been imaged within the previous year and 38% within the previous 100 days.
| The yield of ED neuroimaging
ED neuroimaging led to an acute change in management in 5 OHSU patients (2.7% of all OHSU patients with ED neuroimaging). Clinical details are provided in Table 2 . Three patients were admitted to the hospital due to a new subdural hematoma, one with known acute head trauma. Two others were admitted due to concerns for small subarachnoid bleeds. Both were subsequently determined to be imaging artifact (false positives), and the patients were discharged.
ED neuroimaging led to an acute change in management for 6 VAPOR patients (3.1% of all VAPOR patients with ED neuroimaging; Table 2 ). Three had experienced a ground-level fall associated with seizures and had intracranial hemorrhage or subdural hematoma on ED neuroimaging. One patient had a prior history of seizures associated with posterior reversible encephalopathy syndrome (resolved for >1 year) and ED neuroimaging suggested recurrence. One patient presented with epilepsia partialis continua associated with a known metastatic brain tumor, enlarged on ED neuroimaging. He was admitted to the hospital for oncology consultation and seizure control. The sixth patient had a history of recurrent subarachnoid bleeding from a venous angioma. ED neuroimaging raised a question of another bleed, leading to hospital admission. This was subsequently reread as imaging artifact, and the patient was discharged.
For both hospitals, combined yield of ED neuroimaging for nonindex seizures was 2.9% (95% CI 1.2%-4.6%). Excluding the 3 patients with false-positive imaging findings, the yield of ED neuroimaging decreased to 2.1% (0.7%-3.5%).
Four additional patients had ED neuroimaging evidence for progression of known disease. Three (1 OHSU, 2 VAPOR) had enlargement of known brain tumors. One VAPOR patient had evidence of increased subcortical white matter disease as compared to a previous CT scan. These findings did not result in an acute change in management, and all patients were discharged from the ED to home. Among patients with previous neuroimaging available, there were no instances in which ED neuroimaging established a new cause for the patient's seizure disorder.
| Clinical factors associated with obtaining ED neuroimaging
Patients with ED neuroimaging were an average of 7 years older than those not imaged (P < 0.001, OHSU or VAPOR). We evaluated 10 other clinical factors that may have influenced the decision to obtain ED neuroimaging (convulsive seizure, acute head injury, presentation with status epilepticus or ARS, alcohol-related seizures, focal seizure onset, focal neurologic examination, prolonged AOC, history of brain tumor, history of cortical stroke, history of TBI). Each factor was coded as present or absent. ORs and CIs for ED neuroimaging were calculated separately for the OHSU and VAPOR samples. Because there were no significant differences in ORs between the 2 hospitals for any of these factors, the results were combined. Acute head injury (OR 8.3, P < 0.001) and prolonged AOC (OR 7.5, P < 0.001) were associated with the highest univariate ORs for obtaining ED neuroimaging (Table 3) . Overall, 83% of patients with acute head injury were imaged, although this group accounted for only 23% of all patients with ED neuroimaging. Other factors (focal neurologic examination, focal seizure onset, alcohol-related seizures, status epilepticus, history of brain tumor) also had elevated ORs for obtaining ED neuroimaging. ORs for convulsive seizure and history of TBI were not significantly elevated. Logistic regression was utilized to determine the influence of multiple factors on obtaining ED neuroimaging. The final model included acute head injury (OR 11.8, Wald CI 6.7-21.0), prolonged AOC (6.0, 2.5-14.3), history of brain tumor (4.5, 2.5-8.3), alcohol-related seizure (2.8, 1.6-4.9), focal neurologic examination (2.4, 1.4-3.9), and age (0.96; 0.95-0.97). Each of these factors was significant at P < 0.001. Convulsive seizure (1.6, 1.1-2.2) and focal seizure onset (1.7, 1.1-2.8) were marginally significant (P = 0.02).
T A B L E 2 Patients with an acute change in management related to emergency department (ED) neuroimaging
Patient
| Factors associated with an increased yield of ED neuroimaging
We also examined the influence of these 10 clinical/historical factors on the yield of ED neuroimaging (Table 4) . As above, ORs were calculated separately for the OHSU and VAPOR samples, and results were combined as there were no significant differences. On univariate analysis, 3 factors were associated with an increased yield of ED neuroimaging: acute head injury (OR 6.2, P < 0.001), prolonged AOC (OR 6.5, P = 0.002), and a focal ED neurologic examination (OR 4.0, P = 0.02). A fourth factor, status epilepticus/ARS, approached statistical significance (OR 3.0, P = 0.07). All other factors were nonsignificant. The logistic regression model contained the same 3 factors: acute head injury (OR 9.4, Wald CI 2.5-35.4; P < 0.001), prolonged AOC (7.8, 1.8-33.7; P < 0.001), and a focal neurologic examination (4.6, 1.2-17.3; P = 0.01).
One or more of these 3 clinical factors (acute head injury, prolonged AOC, focal examination) were present in 48% of all ED visits that included neuroimaging, and all 3 were absent in 52% of visits. At least one of these 3 clinical factors was present in 9 of 11 ED visits in which ED neuroimaging led to an acute change in management. Absent any of these 3 factors the yield of ED neuroimaging was 1% (2 of 198 scans). Both of these cases were due to false-positive imaging that led to hospitalization (Table 2 , patients OHSU3, VAPOR6). Excluding these false-positives, the yield of ED neuroimaging was zero when all three clinical factors were absent (95% CI 1.8%).
| DISCUSSION
Our findings from a review of 822 ED visits for nonindex seizures can be summarized as follows: (1) The overall frequency of ED neuroimaging in patients presenting with nonindex seizures was 46%.These were primarily CT scans. (2) The yield of ED neuroimaging, findings that led to an acute change in management, was less than 3%. Included within the 3% were several false positives that nonetheless led to a change in care. Excluding false positives, the yield was 2%. (3) The yield of ED neuroimaging was increased in patients with acute head trauma, prolonged AOC, or a focal abnormality on the ED neurologic examination. Absent these clinical factors the yield fell to 1%, zero after excluding false positives.
Most seizure patients presenting to the ED do not have new-onset seizures. [5] [6] [7] In this study, 78% of all seizurerelated ED visits involved patients with known seizure disorders (nonindex seizures). Most patients with nonindex seizures had been evaluated previously. Nearly 90% of patients who underwent ED neuroimaging had previous neuroimaging results available in the EMR, and 67% of these scans were obtained within the previous year. Potentially epileptogenic lesions, if present, were likely discovered on previous imaging. Repeat imaging in the ED had a low likelihood of clinically significant new findings. Only one adult study (60 patients) evaluated ED CT scans in patients with known seizures. 10 Abnormalities were noted in 20% of scans, but it was not clear whether these were old or new findings, or whether they impacted patient management. Three clinical factors were associated with an increased yield of ED neuroimaging: acute head injury, prolonged AOC, and a focal abnormality on the ED neurologic examination. A fourth, presentation with status epilepticus/ARS, bordered on statistical significance and might have reached significance in a larger series. Our findings regarding factors associated with an increased yield of neuroimaging are generally consistent with those of previous studies that primarily evaluated patients with new-onset seizures. 8, 10, 11, 14 Absent any of the 3 significant factors, ED neuroimaging led to an acute change in care for only 2 patients (1%), and both were later determined to be false-positive imaging findings. Our results suggest that selecting patients for ED neuroimaging based on a small group of clinical factors at ED presentation could decrease the number of scans performed with minimal loss of yield. The impact could be substantial given that 52% of patients who underwent neuroimaging in the present study had none of the 3 significant factors present.
Other clinical/historical factors were not associated with an increased yield of ED neuroimaging, although several were associated with the decision to obtain imaging. Presentations with convulsive seizures, alcohol-related seizures, or focal progression of the seizure were not associated with an increased yield of neuroimaging, and neither was a prior history of brain tumor, stroke, or TBI.
Head CT is generally considered a benign procedure. However, overuse is problematic. Cost is one concern. There are~1 million ED visits for seizures each year in the United States, with 80% involving patients with known seizure disorders. [2] [3] [4] [5] [6] If 46% underwent ED neuroimaging (as in our sample), and with an average cost of $1000, the projected annual cost would be $460 million. 15 Decreasing ED neuroimaging by 50% could result in substantial savings. Another problem is time spent in obtaining neuroimaging, including movement to and from the scanner. This impacts workflow within the ED and may delay care. Several of our patients had seizures while at the scanner, thereby complicating management. There is a risk of false-positive neuroimaging. In our series, 3 scans were initially read as showing a possible small intracranial bleed, contributing to the decision to admit to the hospital. Follow-up scans were negative. In addition, radiation exposure from a head CT scan is estimated at 2 mSv, the equivalent of 10 chest x-rays. Several patients reviewed for this study had multiple ED visits and head CTs, adding to total exposure. There are limitations to the interpretation of these results. ED visits were obtained from 2 urban hospitals, a university hospital and an urban VA medical center. Although findings were similar at the 2 hospitals, it is unknown whether these results are broadly applicable. Private hospitals, and hospitals that are part of comprehensive health plans such as Kaiser Permanente, may have different cultures, and the frequency of ED neuroimaging could be higher or lower. Geographic location and socioeconomic factors may have also influenced our results. Our analysis is based on a retrospective chart review. To minimize bias, we included all patients within the selected time frames at each hospital. However, other sources of bias may have been present. The yield of ED neuroimaging in this study was <3% (including false positives), 11 patients in total. Given the small number of patients, our results regarding factors associated with the yield of ED neuroimaging should be interpreted cautiously. Replication of these findings in an independent sample would be important for confirming these results.
In conclusion, these results support a more conservative use of ED neuroimaging for nonindex seizures, based on clinical factors at the time of presentation. Limiting scans to patients with acute head trauma, prolonged AOC, or a focal neurologic examination would have eliminated more than 50% of scans performed in our EDs, with no impact on yield. Neuroimaging continues to play an important role in the emergency evaluation of seizures. The clinician's decision to obtain neuroimaging in any individual presenting to the ED is complex and may depend on details of the history and examination that were not captured in this chart review. In practice, patients presenting with an acute change in seizure pattern (such as status epilepticus), or those with a known neoplastic lesion, may benefit from imaging, even though yield is low. Our results can only provide general guidance. However, without specific indications, ED neuroimaging for nonindex seizures is unlikely to result in an acute change in care.
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